10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.

By F. Hamdy, J. Donovan, J. Lane, M. Mason, C. Metcalfe, P. Holding, M. Davis, Timothy J. Peters, Emma L Turner, Richard M. Martin and 17 more. New England Journal of Medicine, 2017

2,348 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Radiation

View Paper: https://www.semanticscholar.org/paper/2699244ded0b2e6789ad2cf7e6cfa24ab7f50806

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Nelson
2. S. Freedland
3. M. Sanda
4. J. Cadeddu
5. Ronald C. Chen
6. J. Treadwell
7. J. Fontanarosa
8. D. Makarov

Citations in the corpus

• Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options (2017, background): “In the PIVOT and ProtecT studies, 20% and 50%, respectively, of patients who started on active surveillance received treatment within 10 years.(17,18) Men with a family history of aggressive prostate cancer characterized by early metastasis may not be ideal candidates for active surveillance even wh”
• MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (2018, neutral): “High-grade prostatic intraepithelial neoplasia 4 (2) 10 (4)”